Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on December 3, 2008
J Am Soc Nephrol 20: 255-259, 2009
© 2009 American Society of Nephrology
doi: 10.1681/ASN.2008030267

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
ASN.2008030267v1
20/2/255    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rozen, E. J.
Right arrow Articles by Encinas, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rozen, E. J.
Right arrow Articles by Encinas, M.

BRIEF COMMUNICATIONS

Loss of Sprouty1 Rescues Renal Agenesis Caused by Ret Mutation

Esteban J. Rozen*, Hagen Schmidt{dagger}, Xavier Dolcet{ddagger}, M. Albert Basson{dagger}, Sanjay Jain§ and Mario Encinas*

* Cell Signaling and Apoptosis Group and {ddagger} Grup de Patologia Oncològica, Institut de Recerca Biomedica de Lleida, Lleida, Spain; {dagger} Department of Craniofacial Development, King's College London, London, United Kingdom; and § Department of Medicine, Renal Division, and HOPE Center for Neurodegenerative Diseases, Washington University School of Medicine, St. Louis, Missouri

Correspondence: Dr. Mario Encinas, Departament de Medicina Experimental, Laboratori d'Investigacio UdL/HUAV, Hospital Universitari Arnau de Vilanova, 1a planta, Rovira Roure, 80, Lleida 25198, Spain. Phone/Fax: +34-973702213; E-mail: mario.encinas{at}mex.udl.cat

Received for publication March 6, 2008. Accepted for publication August 11, 2008.

Renal morphogenesis requires a balance between positive and negative signals, which are provided in part by the receptor tyrosine kinase Ret and the putative tumor suppressor Sprouty1, respectively. Tyrosine 1062 of Ret is a binding site for several adaptor and effector proteins, such as Grb2/Sos/Ras, which activate the ERK pathway. Mice lacking Ret tyrosine 1062 nearly mimic the phenotype of Ret-knockout mice, which includes renal agenesis. Sprouty1 regulates Ret activity by modulating the ERK pathway, but the mechanism by which this occurs is uncertain. Here, we show that loss of Sprouty1 rescues the renal agenesis and early postnatal lethality caused by lack of Ret tyrosine 1062. The kidneys and lower urinary tracts of double-mutant mice developed normally. This effect was specific to the urinary system, because loss of Sprouty1 did not rescue the defects in the enteric nervous system characteristic of animals lacking Ret tyrosine 1062. These results suggest that Sprouty1 can modulate ERK signaling downstream of Ret, independent of Grb2/Sos/Ras, during renal morphogenesis.







HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP